LCTX

Lineage Cell Therapeutics Inc

$1.71

+0.02 (+1.18%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 07.10.2025
$4.17
(+143.68%)
Strong Buy: 2
Buy: 4
Hold: 1
Sell: 0
Strong Sell: 0
Description:
Lineage Cell Therapeutics, Inc. is a innovative clinical-stage biotechnology company based in Carlsbad, California, dedicated to the development and commercialization of novel therapeutics aimed at treating degenerative diseases globally. With a strong emphasis on regenerative medicine, the company leverages its proprietary cell-based therapies to address significant unmet medical needs. Lineage's robust pipeline and strategic partnerships position it as a key player in the biotech sector, offering potential for substantial growth as it advances its candidates through clinical trials.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
2173 SALK AVENUE, CARLSBAD, CA, UNITED STATES, 92008
Fiscal year end:
December
Market capitalization:
$386 Million
EBITDA:
-$19.8 Million
PERatio:
0.0
EPS:
-0.17
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.778

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-24%
How much will you get:
$757
Prices dates:
30-09-2015: $2.23 and 30-09-2025: $1.69